The Lab at Onward – Trademark Portfolio

Entity Type: 99

The Lab at Onward holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 25 (Clothing) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include WOVE and THE LAB AT ONWARD. The owner is based in Bath, ME.

PO Box 476

Bath, ME 04530

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

The Lab at Onward's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

25
Clothing (1 filing)

Clothing, footwear, headgear

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does The Lab at Onward have?

The Lab at Onward has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does The Lab at Onward file in?

The Lab at Onward files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 25 (Clothing), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.

What are The Lab at Onward's most well-known trademarks?

The Lab at Onward's registered trademark portfolio includes well-known marks such as WOVE and THE LAB AT ONWARD. These are among 2 currently registered trademarks in the portfolio.

What is The Lab at Onward's trademark registration success rate?

The Lab at Onward has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.